{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:48:59Z","timestamp":1792511339796,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of War","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.xcrm.2026.103083","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:26:06Z","timestamp":1790781966000},"page":"103083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["EZH2-dependent phenotypic plasticity reveals TTP-associated and mTORC1 therapeutic vulnerabilities in lethal prostate cancer"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5105-4583","authenticated-orcid":false,"given":"Beatriz","family":"German","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teia","family":"Noel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Boufaied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah L.","family":"Burkhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Dezem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry W.","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Lin","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"DiFazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvan","family":"Baca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha A.","family":"Shafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himisha","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Housheng Hansen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmine T.","family":"Plummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon.R.V.","family":"Knott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Labb\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4739-5049","authenticated-orcid":false,"given":"Leigh","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.103083_bib1","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1078-0432.CCR-15-1259","article-title":"Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers","volume":"22","author":"Aparicio","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103083_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103083_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103083_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1615\/CritRevOncog.2022043096","article-title":"Phenotypic Plasticity - Alternate Transcriptional Programs Driving Treatment Resistant Prostate Cancer","volume":"27","author":"Nanda","year":"2022","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.xcrm.2026.103083_bib5","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103083_bib6","doi-asserted-by":"crossref","first-page":"E6544","DOI":"10.1073\/pnas.1518007112","article-title":"A basal stem cell signature identifies aggressive prostate cancer phenotypes","volume":"112","author":"Smith","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103083_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature03664","article-title":"Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma","volume":"436","author":"Garraway","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103083_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002003","article-title":"Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.103083_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI151666","article-title":"Reversal of viral and epigenetic HLA class I repression in Merkel cell carcinoma","volume":"132","author":"Lee","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103083_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/epigenomes6030028","article-title":"Polycomb Directed Cell Fate Decisions in Development and Cancer","volume":"6","author":"German","year":"2022","journal-title":"Epigenomes"},{"key":"10.1016\/j.xcrm.2026.103083_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cell.2006.02.041","article-title":"A bivalent chromatin structure marks key developmental genes in embryonic stem cells","volume":"125","author":"Bernstein","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib12","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.cell.2016.04.031","article-title":"Acquired Tissue-Specific Promoter Bivalency Is a Basis for PRC2 Necessity in Adult Cells","volume":"165","author":"Jadhav","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib13","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-024-51156-5","article-title":"Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes","volume":"15","author":"Venkadakrishnan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103083_bib14","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/35020506","article-title":"Regulation of chromatin structure by site-specific histone H3 methyltransferases","volume":"406","author":"Rea","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103083_bib15","doi-asserted-by":"crossref","first-page":"10929","DOI":"10.1093\/nar\/gkac861","article-title":"A cryptic transactivation domain of EZH2 binds AR and AR's splice variant, promoting oncogene activation and tumorous transformation","volume":"50","author":"Wang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.103083_bib16","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/1541-7786.MCR-19-1245","article-title":"Targeting RET Kinase in Neuroendocrine Prostate Cancer","volume":"18","author":"VanDeusen","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103083_bib17","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2016.07.007","article-title":"Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer","volume":"166","author":"Drake","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib18","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/s43018-022-00431-9","article-title":"Ectopic JAK-STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance","volume":"3","author":"Deng","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.103083_bib19","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1080\/15548627.2015.1117734","article-title":"Epigenetic regulation of autophagy by the methyltransferase EZH2 through an MTORC1-dependent pathway","volume":"11","author":"Wei","year":"2015","journal-title":"Autophagy"},{"key":"10.1016\/j.xcrm.2026.103083_bib20","first-page":"2608","article-title":"GSK343 induces autophagy and downregulates the AKT\/mTORC1 signaling pathway in pancreatic cancer cells","volume":"18","author":"Xu","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.xcrm.2026.103083_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2303010120","article-title":"Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways","volume":"120","author":"Liu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103083_bib22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13008-020-00064-3","article-title":"EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin","volume":"15","author":"Chen","year":"2020","journal-title":"Cell Div."},{"key":"10.1016\/j.xcrm.2026.103083_bib23","doi-asserted-by":"crossref","DOI":"10.15252\/embj.201899599","article-title":"EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasis","volume":"38","author":"Zhao","year":"2019","journal-title":"EMBO J."},{"key":"10.1016\/j.xcrm.2026.103083_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1158\/2159-8290.CD-19-0152","article-title":"Loss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic Transformation","volume":"9","author":"Gu","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103083_bib25","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s42003-020-01476-1","article-title":"Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer","volume":"3","author":"Dong","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.xcrm.2026.103083_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.5751","article-title":"Single-cell analysis of mouse and human prostate reveals novel fibroblasts with specialized distribution and microenvironment interactions","volume":"255","author":"Joseph","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.xcrm.2026.103083_bib27","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.celrep.2018.11.086","article-title":"A Cellular Anatomy of the Normal Adult Human Prostate and Prostatic Urethra","volume":"25","author":"Henry","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103083_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","article-title":"RNA velocity of single cells","volume":"560","author":"La Manno","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.103083_bib29","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1038\/s41467-023-42841-y","article-title":"A statistical framework for differential pseudotime analysis with multiple single-cell RNA-seq samples","volume":"14","author":"Hou","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103083_bib30","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2026.103083_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13059-015-0843-6","article-title":"Quality control, modeling, and visualization of CRISPR screens with MAGeCK-VISPR","volume":"16","author":"Li","year":"2015","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.103083_bib32","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1186\/s13059-014-0554-4","article-title":"MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens","volume":"15","author":"Li","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2026.103083_bib33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.celrep.2013.01.010","article-title":"Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor","volume":"3","author":"Mohammed","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.103083_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79076","article-title":"Defining cellular population dynamics at single-cell resolution during prostate cancer progression","volume":"11","author":"Germanos","year":"2022","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2026.103083_bib35","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1158\/1535-7163.MCT-15-0996","article-title":"Characterization of LY3023414, a Novel PI3K\/mTORC1 Dual Inhibitor Eliciting Transient Target Modulation to Impede Tumor Growth","volume":"15","author":"Smith","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.xcrm.2026.103083_bib36","first-page":"114","article-title":"Interleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer","volume":"6","author":"Cunningham","year":"2018","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.xcrm.2026.103083_bib37","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/s41467-018-04495-z","article-title":"Patient derived organoids to model rare prostate cancer phenotypes","volume":"9","author":"Puca","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103083_bib38","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","article-title":"Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial","volume":"21","author":"Morschhauser","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.103083_bib39","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1158\/1078-0432.CCR-17-3421","article-title":"A First-in-Human Phase 1 Study of LY3023414, an Oral PI3K\/mTORC1 Dual Inhibitor, in Patients with Advanced Cancer","volume":"24","author":"Bendell","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.103083_bib40","article-title":"Low tristetraprolin expression activates phenotypic plasticity and primes transition to lethal prostate cancer in mice","volume":"135","author":"Morel","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103083_bib41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.mad.2010.02.002","article-title":"Protein phosphatase 2A (PP2A) is increased in old murine B cells and mediates p38 MAPK\/tristetraprolin dephosphorylation and E47 mRNA instability","volume":"131","author":"Frasca","year":"2010","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.xcrm.2026.103083_bib42","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/2159-8290.CD-11-0130","article-title":"Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets","volume":"1","author":"Beltran","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103083_bib43","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ccell.2017.09.003","article-title":"Androgen Receptor Pathway-Independent Prostate Cancer Is Sustained through FGF Signaling","volume":"32","author":"Bluemn","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103083_bib45","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cell.2014.08.017","article-title":"Identification of multipotent luminal progenitor cells in human prostate organoid cultures","volume":"159","author":"Karthaus","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.aay0267","article-title":"Regenerative potential of prostate luminal cells revealed by single-cell analysis","volume":"368","author":"Karthaus","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103083_bib47","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccr.2012.01.005","article-title":"Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation","volume":"21","author":"Choi","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib48","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0002-9440(10)64286-1","article-title":"Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy","volume":"162","author":"van Leenders","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.103083_bib49","doi-asserted-by":"crossref","first-page":"20111","DOI":"10.1073\/pnas.1320565110","article-title":"Prostate cancer originating in basal cells progresses to adenocarcinoma propagated by luminal-like cells","volume":"110","author":"Stoyanova","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103083_bib50","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.1189992","article-title":"Identification of a cell of origin for human prostate cancer","volume":"329","author":"Goldstein","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103083_bib51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm.4036","article-title":"Targeting EZH2 in cancer","volume":"22","author":"Kim","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.103083_bib52","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1038\/s41467-024-53874-2","article-title":"Increased translation driven by non-canonical EZH2 creates a synthetic vulnerability in enzalutamide-resistant prostate cancer","volume":"15","author":"Chatterjee","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.103083_bib53","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1227604","article-title":"EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent","volume":"338","author":"Xu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.103083_bib54","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.molcel.2011.08.011","article-title":"Context-specific regulation of NF-kappaB target gene expression by EZH2 in breast cancers","volume":"43","author":"Lee","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential","volume":"6","author":"Gan","year":"2018","journal-title":"Biomark. Res."},{"key":"10.1016\/j.xcrm.2026.103083_bib56","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.18632\/oncotarget.1314","article-title":"Combinatorial antitumor effect of HDAC and the PI3K-Akt-mTORC1 pathway inhibition in a Pten defecient model of prostate cancer","volume":"4","author":"Ellis","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.103083_bib57","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/2767-9764.CRC-23-0250","article-title":"Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers","volume":"3","author":"Zhang","year":"2023","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.xcrm.2026.103083_bib58","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/1878-0261.13703","article-title":"Assessments of prostate cancer cell functions highlight differences between a pan-PI3K\/mTORC1 inhibitor, gedatolisib, and single-node inhibitors of the PI3K\/AKT\/mTORC1 pathway","volume":"19","author":"Sen","year":"2025","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.xcrm.2026.103083_bib59","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/1878-0261.13577","article-title":"Dual targeting of the androgen receptor and PI3K\/AKT\/mTORC1 pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis","volume":"18","author":"Sugawara","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.xcrm.2026.103083_bib60","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/2159-8290.CD-16-1174","article-title":"Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer","volume":"7","author":"Zou","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.103083_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145098","article-title":"Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma","volume":"21","author":"Bell","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.103083_bib62","doi-asserted-by":"crossref","first-page":"57514","DOI":"10.18632\/oncotarget.11583","article-title":"NFIB overexpression cooperates with Rb\/p53 deletion to promote small cell lung cancer","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.103083_bib63","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cell.2016.05.052","article-title":"Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility","volume":"166","author":"Denny","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib64","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1158\/2767-9764.CRC-24-0069","article-title":"MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer","volume":"4","author":"German","year":"2024","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.xcrm.2026.103083_bib65","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.09.005","article-title":"N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer","volume":"30","author":"Dardenne","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.103083_bib66","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI127961","article-title":"N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer","volume":"129","author":"Berger","year":"2019","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103083_bib67","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.tcb.2023.07.012","article-title":"Patterns in the tapestry of chromatin-bound RB","volume":"34","author":"Sanidas","year":"2024","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.xcrm.2026.103083_bib68","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175217","article-title":"Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer","volume":"134","author":"Ku","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.103083_bib69","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1073\/pnas.1905384117","article-title":"Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1","volume":"117","author":"Hsu","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.103083_bib70","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2026.103083_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126005008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126005008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:14:58Z","timestamp":1792509298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126005008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":71,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2666379126005008"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103083","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EZH2-dependent phenotypic plasticity reveals TTP-associated and mTORC1 therapeutic vulnerabilities in lethal prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.103083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103083"}}